Financials

  • Market Capitalization 9.12 B
  • Employee 253
  • Founded 2015
  • CEO N/A
  • Website www.kymeratx.com
  • Headquarter Delaware, United States
  • FIGI BBG00SDHC8D1
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-23.27
Relación precio/flujo de caja
148.57

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
925
NUVL
Nuvalent, Inc. - Class A Common Stock
123.96 USD0.00%+0.18%+0.45%+30.55%9.79 B USD
930
CORT
Corcept Therapeutics Incorporated - Common Stock
88.61 USD-2.06%-5.99%+6.53%+20.77%9.51 B USD
959
PRAX
Praxis Precision Medicines, Inc. - Common Stock
322.19 USD-1.68%-2.65%+21.61%+518.64%8.98 B USD
966
IONS
Ionis Pharmaceuticals, Inc. - Common Stock
53.78 USD-2.09%-37.02%-27.26%-25.44%8.89 B USD

Noticias